Literature DB >> 17393130

[Drug information services for physicians and patients. Acceptance and benefits].

A Fuchs1, U Winkler, U Maywald, W Kirch.   

Abstract

The growing number of medicinal products and innovations has led to great complexity in the pharmaceutical market. The variety of possible drug interactions and side effects can only be overviewed with difficulty. Therefore, it is necessary that services for physicians be offered in order to provide critically evaluated and independent drug information for pharmacotherapy. In recent decades, a series of hospital based drug information centres have been established. Their quality and usefulness for patients have been positively evaluated by the users. Many patients are also insufficiently informed on their own drug therapy. This deficit is based on a general lack in communication between the patient and physician. Patient-orientated drug information services can help strengthen patients in their drug therapy and self management of symptoms, and to improve compliance. Such services have also been positively evaluated by patients.

Entities:  

Mesh:

Year:  2007        PMID: 17393130     DOI: 10.1007/s00108-007-1829-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  Regional drug information service.

Authors:  U I Schwarz; S Stoelben; U Ebert; M Siepmann; J Krappweis; W Kirch
Journal:  Int J Clin Pharmacol Ther       Date:  1999-06       Impact factor: 1.366

2.  Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?

Authors:  Jan Schjøtt; Erik Pomp; Ane Gedde-Dahl
Journal:  Eur J Clin Pharmacol       Date:  2002-02       Impact factor: 2.953

3.  [Management of diabetes and hypertension: how do primary care physicians judge their performance?].

Authors:  P Krause; H U Wittchen; B Küpper; D Pittrow; T Unger; A M Sharma; E Ritz; B Göke; H Lehnert; D Tschöpe; W Kirch; H Pfister; P Bramlage; M Höfler
Journal:  Fortschr Med Orig       Date:  2003-02-27

4.  [Quality of health care in Germany. A six-country comparison].

Authors:  Peter T Sawicki
Journal:  Med Klin (Munich)       Date:  2005-11-15

5.  Drug information services: initial experiences in Dresden.

Authors:  U I Schwarz; J Krappweis; S Stoelben; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1998-10       Impact factor: 2.953

6.  Economic impact of a drug information service.

Authors:  D E Kinky; S C Erush; M S Laskin; G A Gibson
Journal:  Ann Pharmacother       Date:  1999-01       Impact factor: 3.154

7.  [Drug information centers-instruments for health care research?].

Authors:  Isabel Hach; Dirk Meusel; Ulf Maywald; Wilhelm Kirch
Journal:  Med Klin (Munich)       Date:  2005-07-15

8.  Therapeutic consultation: a necessary adjunct to independent drug information.

Authors:  C Rodríguez; J M Arnau; X Vidal; J R Laporte
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

9.  [Drug information for patients -- unmet needs, evaluation and influence on the compliance].

Authors:  U Maywald; C Schindler; Y Bux; W Kirch
Journal:  Dtsch Med Wochenschr       Date:  2005-06-17       Impact factor: 0.628

10.  The impact of CyberHealthcare on the physician-patient relationship.

Authors:  James G Anderson; Michelle R Rainey; Gunther Eysenbach
Journal:  J Med Syst       Date:  2003-02       Impact factor: 4.460

View more
  1 in total

1.  [6-year experience with a drug information service for patients].

Authors:  Martin Huber; Gerd A Kullak-Ublick; Wilhelm Kirch
Journal:  Med Klin (Munich)       Date:  2009-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.